MENU
CAPR
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Capricor Therapeutics (CAPR) Ownership - Who owns Capricor Therapeutics?
Capricor Therapeutics Inc is a biotechnology company focused on advancing transformative cell and exosome-based therapeutics to redefine the treatment landscape for rare diseases... Show more
Industry: #Biotechnology
Profile
Industry
Biotechnology
Address
10865 Road to the Cure
Phone
+1 858 727-1755
Employees
102
Web
https://www.capricor.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
539.66M
P/E Ratio
N/A
Total Cash
85.03M
Projected Growth
N/A
Total Debt
1.65M
Revenue
23.23M
Risk (Beta)
1.30
Dividend Yield
N/A
Total Cash/Share
1.86
Total Debt/Equity
N/A
Revenue/Share
0.63 USD as % of share price
Fundamentals
CAPR
Capitalization
540M
P/E Ratio
N/A
Risk (Beta)
1.30
Dividend Yield
N/A
Total Cash
85M
Total Cash/Share
1.86
Total Debt
1.65M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.63%
Revenue
23.2M
ROE
N/A
Book Value
68.3M
P/B Ratio
3.61
Cash Flow
N/A
Earnings
-1.02
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
40.3K
Current Ratio
4.19
Current Revenue Per Employee
22172.96
Dividends Per Share - Security
N/A
EBITDA
-34.79M
Float
N/A
Float - Current
N/A
Gross Income Margin
100.00
Revenue To Assets
-52.44
Shares Held By Institutions
345M
Shares Outstanding - Current
45.7M
Total Liabilities
24.7M
Total Volume MTD
N/A
Value
-1
Gain YTD
-16.667
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Develops innovative products for the treatment of cardiovascular diseases
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
10865 Road to the Cure
Phone
+1 858 727-1755
Employees
102
Web
https://www.capricor.com